Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1994-11-07
1998-11-10
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
549 1, 424 165, A61K 5100, A61M 3614
Patent
active
058339442
ABSTRACT:
This invention provides a novel compound for .sup.35 S-labelling oligonucleotides. The compound is .sup.35 S-3H-1,2-benzodithiol-3-one-1,1 dioxide (1) ##STR1## wherein the asterisk indicates the position of the .sup.35 S. Also provided is a method of synthesizing this compound, comprising first contacting .sup.35 S-thiobenzoic acid (4) with thiosalicylic acid (5) in acid medium to yield the condensation product, .sup.35 S-3 H 1,2-benzodithiol-3-one (2). .sup.35 S-3 H 1,2-benzodithiol-3-one (2) is then oxidized with a suitable oxidating agent such as trifuoroacetic acid and hydrogen perioxide to yield the desired product, .sup.35 S-3H-1,2-benzodithiol-3-one-1,1 dioxide (1). Any oligonucleotide susceptible to oxidative sulfurized by 3H-1,2-benzodithiol-3-one-1,1 dioxide can be labeled by .sup.35 S-3H-1,2-benzodithiol-3-one-1,1 dioxide (1). Accordingly, this invention also provides novel methods for .sup.35 S-labelling oligonucleotides. The compound and methods are useful for tracing biodistribution and degradation of antisense oligonucleotides in pharmacokinetic studies.
REFERENCES:
patent: 4139362 (1979-02-01), Rasheed et al.
patent: 4175186 (1979-11-01), Rasheed et al.
patent: 5003097 (1991-03-01), Beaucage et al.
patent: 5149798 (1992-09-01), Agrawal et al.
Rao and MacFarlane. Tetrahedron Letters, vol. 35, No. 36, pp. 6741-6744 (1994) "Solid Phase Synthesis of Phosphorothiolate Oligonucleotides Using Benzytriethylammonium Tetrathiomolybdate as a Rapid Sulfur Transfer Reagent".
Wyrzykiewicz and Ravikumar. Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 12, pp. 1519-1522 (1994), Efficiency of Sulfurization in the Synthesis of Oligodeoxyribonucleotide phosphorothioates utilizing various sulfurizing reagents.
Hortmann et al. J. Org. Chem., vol. 43, No. 17, pp. 3374-3378 (1978) "3H-1,2-Benzodithiole Oxides: Studies Directed toward the Generation of
Stawinski and Thelin. J. Org. Chem., vol. 56, pp. 5169-5175 (1991) "Nucleoside H-Phosphonates. 13. Studies on 3H-1,2-benzodithiol-3-one Derivatives as Sulfuring reagents for H-Phosphonates and H-Phosphonothioate Diesters".
Iyer et al. J Org. Chem. (1990), 55, pp. 4693-4699, The Automated Synthesis of Sulfur Containing Oligodeoxyribonucleotides using 3H-1,2-benzodithiol-3-One 1,1-Dioxide as a sulfur transfer reagent.
Regan et al. Org. Prep. Proced. Int (1992), 24(4) pp. 488-492 Large-Scale Preparation of the Sulfur transfer reagent 3-H-1,2-benzodithiol-3-one 1,1,-dioxide.
Holum Elements of General, Organic, and Biological Chemistry, 9th edition, pp. 40-42.
The Merck Index, 9.sub.th edition, p. 1162, Compound 8764.
Becaucage and Iyer. Tetrahedron, vol. 49, No. 10, pp. 1925-1963 (1993). "The Functionalization of Oligonucleotides Vici Phosphoramidite Derivatives".
Stawinski et al. Nucleosides and Nucleotides, vol. 10, No. 1-3, pp. 517-518 (1991). "Studies on Sulfurization of Nucleoside H-Phosphonate and H-Phosphonothioate Esters Using 3H-1,2-Benzodithiol-3-One 1,1-dioxide".
Iyer et al. J. Am. Chem. Soc., vol. 112, pp. 1253-1254, "3H-1,2-benzodithiole-3-one 1,1-Dioxide as an Improved Sulfurzing Reagent in the Solid-Phase Synthesis of Oligodeoxyribonucleoside Phosphorothioates".
Iyer et al. Tetrahedron Letters, vol. 35, No. 51, pp. 9521-9524 (1994), Application in the Preparation of site Specifically 35S-labeled Oligonucleotides.
Graham et al. Nucleic Acid Research, vol. 21, No. 16 pp. 3737-3743. "Tritium labeling of antisense oligonucleotides by exchange with tritiated water".
Stein et al., Analytical Biochemistry 188, 11-16 (1990).
Zamecnik and Stephenson, Proc. Natl. Acad. Sci. USA 75, 280-284 (1978).
Agrawal et al., Trends in Biotech. 10, 152-158 (1992).
Uhlmann and Peyman, Chem. Rev. 90, 543 (1990).
See generally, Methods in Molecular Biology, vol. 20: Protocols for Oligonucleotides and Analogs, pp. 165-189 (S. Agrawal, Ed., Humana Press, 1993).
See generally, Oligonucleotides and Analogues: A Practical Approach, pp. 87-108 (F. Eckstein, Ed., 1991).
Khorana et al., J. Molec. Biol. 72, 209 (1972).
Reese, Tetrahedron Lett. 34, 3143-3179 (1978).
Beaucage and Caruthers, Tetrahedron Lett. 22, 1859-1862 (1981).
Beaucage and Iyer, Tetrahedron Lett. 48, 2223 (1992).
Agrawal and Goodchild, Tetrahedron Lett. 28, 3539-3542 (1987).
Connolly et al., Biochemistry 23, 3443 (1984).
Jager et al., Biochemistry 27, 7237 (1988).
Agrawal et al., Proc. Natl. Acad. Sci. USA 85, 7079-7083 (1988).
Padmapriya et al., Antisense Res. & Dev. 4, 185-199 (1994).
Andrad et al., Bioorg. & Med. Chem. Lett., pp. 2017-2022 (1994).
Agrawal et al., Proc. Natl. Acad. Sci. U.S.A. 88, 7595-7599 (1991).
Kawamura et al., Chem. Lett. 1231-1234 (1975).
McKibben and McClelland, J. Chem. Soc., 170-173 (1923).
M. Hudlicky, Oxidation in Organic Chemistry, ACS Monograph 186, 1990.
Agrawal Sudhir
Iyer Radhakrishnan P.
Tan Weitian
Hybridon, Inc.
Jones Dameron L.
Kight John
LandOfFree
Procedure for the solid phase synthesis of .sup.35 S-labeled oli does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Procedure for the solid phase synthesis of .sup.35 S-labeled oli, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Procedure for the solid phase synthesis of .sup.35 S-labeled oli will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1513703